Chlorambucil fails to improve patients with motor neuropathies and antibodies to gangliosides.
Kuntzer
T
T
Steck
A J
AJ
Adams
D
D
Regli
F
F
D000328:Adult; D000368:Aged; D001323:Autoantibodies / Q000032:analysis*; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology; D002699:Chlorambucil / Q000627:therapeutic use*; D005260:Female; D005677:G(M1) Ganglioside / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016472:Motor Neuron Disease / Q000188:drug therapy* / Q000276:immunology; D009460:Neurologic Examination / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology
D001323:Autoantibodies; D002699:Chlorambucil; D005677:G(M1) Ganglioside